Ophthalmic compositions for treating ocular hypertension
US6914070B2 · kind B2 · utility
1Cited by
15References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2003 |
| Grant date | Jul 5, 2005 |
| Priority date | — |
| Expiry date | Oct 9, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.